Vanguard Global Advisers’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.4K Buy
+13,514
New +$27.8K ﹤0.01% 3276
2026
Q2
– Sell
-4,539
Closed -$5.13K – 3690
2026
Q1
$5.13K Hold
4,539
– – ﹤0.01% 3555

Other funds holding INMB

Vanguard Global Advisers's INMB Position: Q3 2026 in Review

Vanguard Global Advisers opened a new position in INmune Bio (INMB) in Q3 2026: 13,514 shares worth $26.4K. The stake represents ﹤0.01% of the portfolio and ranks #3276 among its holdings. This is a return to the name: Vanguard Global Advisers previously reported a position in INMB as recently as Q1 2026.

Vanguard Global Advisers first reported a position in INMB in Q1 2026 and has held it in 2 quarters since. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

  • Vanguard Global Advisers held 13,514 shares of INmune Bio worth $26.4K as of Q3 2026.
  • INmune Bio was a new Vanguard Global Advisers position in Q3 2026.
  • INmune Bio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3276 holding.
  • Vanguard Global Advisers first reported a position in INmune Bio in Q1 2026 and has held it in 2 quarters since.
  • 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.